(Q33921770)

30 July 2017

1 reference

title

Fluoride for treating postmenopausal osteoporosis (English)

1 reference

postmenopausal osteoporosis

30 July 2017

0 references

1 reference

4

P Tugwell

1 reference

30 July 2017

D Haguenauer

1

1 reference

30 July 2017

V Welch

series ordinal

2

1 reference

30 July 2017

B Shea

series ordinal

3

1 reference

30 July 2017

G Wells

series ordinal

5

1 reference

30 July 2017

1 January 2000

1 reference

Cochrane Database of Systematic Reviews

30 July 2017

1 reference

30 July 2017

4

1 reference

30 July 2017

CD002825

1 reference

Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females

30 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002825

Treatment of postmenopausal vertebral osteopenia with monofluorophospate: a long-term calcium-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002825

The effect of fluoride and calcium on spinal bone mineral content: a controlled, prospective (3 years) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002825

A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002825

Treatment of postmenopausal osteoporosis with slow-release sodium fluoride. Final report of a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002825

The effect of sodium monofluorophosphate plus calcium on vertebral fracture rate in postmenopausal women with moderate osteoporosis. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002825

Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002825

Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002825

Effect of sodium fluoride, calcium, phosphate, and vitamin D2 on trabecular bone balance and remodeling in osteoporotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002825

Avoidance of vertebral fractures in men with idiopathic osteoporosis by a three year therapy with calcium and low-dose intermittent monofluorophosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002825

The effect of sodium fluoride on trabecular architecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002825

X-ray microanalysis of fluoride distribution in microfracture calluses in cancellous iliac bone from osteoporotic patients treated with fluoride and untreated

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002825

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002825

Discrepancies in normative data between Lunar and Hologic DXA systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002825

The statistical basis of meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002825

Developing optimal search strategies for detecting clinically sound studies in MEDLINE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002825

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002825

Histomorphometric analysis of iliac crest bone biopsies in placebo-treated versus fluoride-treated subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002825

First- and second-year effects in trials of calcium supplementation on the loss of bone density in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002825

Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002825

Fluoride for the treatment of postmenopausal osteoporotic fractures: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002825

Three Years' Experience with Sodium-Fluoride Therapy of Osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002825

Effect of Sodium Fluoride on Calcium Metabolism of Human Beings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002825

10.1002/14651858.CD002825

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference